Alvotech S.A. (ALVO): Operating Sales Margin

Alvotech Biopharmaceuticals - graphic logo of issuer ALVO

Alvotech's bet on long-lifecycle biosimilars ensures stable income, as illustrated by the operating profit level before interest and taxes. The value 11.50 characterizes this valuation parameter. Alvotech is developing an ecosystem of affordable substitutes for original drugs through global partnerships. A streamlined network of specialized temperature-controlled air freight guarantees supply reliability.

ALVO: alvotech.com Operating Return on Sales 04/28/2023 - 11/19/2026

Alvotech - analytical breakdowns and key metrics (ALVO)

- price and consensus price forecast:
- stock exchange capitalization data:
Basic company analysis:ALVO, Alvotech Corp
Finished products of Alvotech Biopharmaceuticals

A high operating margin confirms the fundamental resilience of the business, demonstrating the ability to generate profit from core operations before taxes and interest obligations. By analyzing the operating margin tracker, an investor assesses the cost management efficiency of Alvotech (ALVO) amid stringent FDA regulatory control and the colossal expenses associated with overcoming patent barriers when launching biosimilars in the US and EU markets.

Key competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Profitability of Operations Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operating Profitability|anipharmaceuticals.com - Operating Profit Rate|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.